Morgan Stanley (MS)
CyclicalFairStock Score: 56/100 — STEADY
Key Financials
| Current Price | $192.51 |
| Market Cap | $254.8B |
| P/E Ratio | 17.44 |
| ROE | 16.39% |
| Dividend Yield | 1.89% |
| Sector | Financial Services |
Strengths
- Exceptional Q4 2025 profitability with 26.23% net margins on $16.8B revenue
- Diversified revenue streams across Institutional Securities, Wealth Management, and Investment Management segments
- Strong market position as a top-tier global capital markets player with 83,000 employees
- ROE of 15.61% demonstrates ability to generate returns on equity capital
- Global geographic diversification reduces concentration risk
Concerns
- Critically low ROCE of 1.29% indicates massive capital deployment for minimal returns
- Piotroski F-Score of 2/9 signals deteriorating financial health across multiple fundamentals
- High leverage with D/E ratio of 4.56 amplifies downside risk in market downturns
- Negative FCF yield of -1.2% and Altman Z-Score of 0.24 suggest financial fragility
- Stock trades at 144% premium to Graham Number fair value estimate of $65.70
AI Analysis
Morgan Stanley presents a classic financial services paradox: excellent near-term earnings power masked by concerning fundamental deterioration. The latest quarter shows a robust 26% net margin on $16.8B revenue, demonstrating the franchise can generate substantial profits. However, I must look beyond quarterly noise to the underlying business quality. The ROE of 15.61% appears respectable, but this masks a troubling reality: a ROCE of just 1.29% suggests the company deploys massive capital to earn minimal returns. With a debt-to-equity ratio of 4.56, Morgan Stanley operates with leverage typical of financial institutions, yet lacks the durable competitive moats I seek. The Piotroski F-Score of 2/9 is deeply concerning—it indicates deteriorating financial health across fundamental metrics. Valuation presents a significant red flag. At a P/E of 15.83 and P/B of 2.51, the stock trades near historical averages for a capital markets business, yet Graham's Number suggests fair value around $65.70—implying a 144% margin of safety in reverse. The negative FCF yield of -1.2% and Altman Z-Score of 0.24 signal financial stress comparable to distressed firms. Morgan Stanley's business model remains cyclical and dependent on capital markets activity. While wealth management provides some stability, the institutional securities division creates volatility. I'm wary of paying full price for a business trading near historic highs with deteriorating fundamentals, elevated leverage, and minimal capital efficiency. This isn't the sort of durable competitive advantage that justifies a premium valuation.
Bull Case
Morgan Stanley's diversified wealth management business is gaining scale and provides more predictable recurring revenue, potentially supporting premium valuations. Strong institutional client relationships and global franchise position enable the firm to capture market share during periods of capital markets strength and M&A activity.
Bear Case
A sharp decline in capital markets activity or equity valuations would severely compress Morgan Stanley's earnings, while the high leverage ratio amplifies losses. If the next financial crisis materializes, the 1.29% ROCE and weak cash flow generation become liabilities rather than assets.
Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer